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Abstract Although the identification of human skin cells is
of important relevance in many forensic cases, there is
currently no reliable method available. Here, we present a
highly specific and sensitive messenger RNA (mRNA)
approach for skin identification, meeting the key require-
ments in forensic analyses. We examined 11 candidate
genes with skin-specific expression, as ascertained from
expression databases and the literature, as well as five
candidate reference genes ascertained from previous stud-
ies, in skin samples and in other forensically relevant
tissues. We identified mRNA transcripts from three genes
CDSN, LOR and KRT9, showing strong over-expression in
skin samples relative to samples from forensic body fluids,
making them suitable markers for skin identification. Out of
the candidate reference genes tested, only ACTB showed
similarly high expression in skin and body-fluid samples,
providing a suitable reference marker for quantitative real-
time PCR (qPCR) analysis of skin. Analyses of palmar and
thumbprint skin samples indicate that our qPCR approach
for the three skin-targeted mRNA markers, as well as the
reference mRNA marker ACTB, is highly sensitive,
allowing successful detection of minute amounts of skin
material including full, half and quarter thumbprints, albeit
with decreased success in decreasing print material.
Furthermore, thumbprints stored for 6.5 months provided
similar results relative to freshly analysed samples implying
reasonable time-wise stability of the three skin-targeted
mRNAs as well as the ACTB reference mRNA. Our study
represents the first attempt towards reliable mRNA-based
skin identification in forensic applications with particular
relevance for future trace/touched object analyses in
forensic case work. Although the approach for skin
identification introduced here can be informative when
applied on its own, we recommend for increased reliability
the integration of (one or more of) the skin-targeted mRNA
markers presented here into multiplex assays additionally
including mRNA markers targeting alternative cell types
expected in forensic samples.
Keywords mRNA.Body-fluid identification.Skin.
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Introduction
A plethora of methods are currently available in forensic
biology to identify the cellular origin of biological traces on
evidential material. Most commonly, presumptive tests are
employed, such as the Phadebas test for saliva, the
ABAcard HemaTrace method for blood, or prostate specific
antigen detection for semen [1]. However, many of these
tests can give false positive results, or their sensitivity level
is too low compared to that of short tandem repeat (STR)
profiling; thus, intensive research is being performed to find
more accurate and more sensitive alternatives to these time-
and sample-consuming tests.
Messenger RNA (mRNA) may provide the necessary
specificity, sensitivity and automation capabilities that
modern forensic biology laboratories require for cellular
origin identification. Each cell type has its own tran-
scriptome, and differences in expression patterns can be
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expression in one relative to the other forensically relevant
cell types (such as body fluids). With the early identification
of various mRNA markers with respective over-expression
in venous blood, menstrual blood, saliva, semen and vaginal
secretions, recent work has focused on refining these mRNA
markers to increase sensitivity or degradation resistance, or
on the development of multiplex assays to allow parallel
testing of several mRNA markers in minute amounts of
sample [2–9]. More recently, micro-RNAs (miRNAs) have
been started to be explored for the forensic determination of
cellular origin [10, 11].
However, at present, there are no mRNA markers
specifically useful for skin cell determination included in
published tissue identification multiplexes. Moreover, there is
currently no widely used presumptive test for the positive
identification of skin material, although alternative light
sources, such as the Polilight, can indicate the presence of
epithelial cells [12], and a histological method is available to
distinguish between skin, buccal and vaginal epithelium [11,
13]. Hence, the ability to conclusively identify and confirm,
on the molecular level, the presence of skin epithelial cells is
still lacking. Given the success of mRNA profiling with
other tissue types of forensic importance, this approach may
also provide potential for skin identification. Being able to
identify skin cells via mRNA profiling would be of
considerable relevance to forensic trace DNA profiling, an
area which has been controversial of late (for a recent
summary, see [14]). Molecular proof that the evidentiary
STR profile on an item originated from skin cells may allow
the linking of the item and the STR profile to the suspect.
This would remove some of the objections to the use of trace
sample amounts for prosecution purposes, by allowing
activity level statements to be made about trace DNA.
The development and maintenance of the outer
epithelial layer of human skin has been comprehensively
studied, and a considerable amount of knowledge has
accumulated regarding the molecular control of epider-
mal cell differentiation. The large stem cell population in
the basal layer of the epidermis continually renews the
skin, differentiating into transit-amplifying cells before
undergoing terminal differentiation [14, 15]. As the cells
migrate upwards through the living spinous and granular
layers, they become progressively keratinised as produc-
t i o no fk e r a t i np r o t e i n s1a n d1 0i n c r e a s e s ,f o l l o w e db yt h e
expression of the proteins filaggrin, involucrin and loricrin
[16]. While undergoing apoptotic-like destruction, the
nuclei are extruded, and the cells become cornified [15].
With the complete renewal of the epidermis every 40–
56 days, humans shed considerable numbers of cells
everyday, containing DNA and stripped nuclei, and
presumably epidermal proteins and mRNA transcripts as
well [17–19].
In the present study, we identified, through thorough
database and literature searches combined with empirical
laboratory testing of candidate markers, a set of mRNA
transcripts that are highly over-expressed in skin epithelial
cells relative to other cell types of forensic relevance, and
performed appropriate tests to describe the sensitivity of the
developed assays and of the time-wise stability of the
proposed markers. We present here a highly specific and
sensitive mRNA approach for skin identification for future
applications in forensic analyses.
Materials and methods
Sample collection
For initial testing of candidate skin and reference genes,
we used venous blood collected by finger prick (n=15)
or venipuncture (n=12), saliva (n=15), semen (n=3),
menstrual blood (n=3), vaginal secretions (n=7), skin
biopsy (n=2) and palmar skin (n=15) samples collected
from healthy volunteers (eight men, seven women,
r a n g i n gf r o m2 2t o4 2y e a r so fa g e )u n d e ri n f o r m e d
consent. All samples from each individual (except for skin
biopsies) were collected within a 1-h period, with skin
sample collection always preceding finger prick blood
collection. For saliva collection, volunteers were asked to
rinse the mouth with cold water 30 min before sampling.
Saliva (3–5 ml) was collected in sterile 50 ml Falcon
polyethylene tubes cooled on ice, with the RNA extracted
immediately to prevent degradation. One saliva soaked
cotton swab per individual was used for RNA isolation.
For skin palmar samples, volunteers were asked to rinse
hands with water (without soap) 30 min before sampling
and to avoid touching other skin or often touched surfaces
(keyboards, etc.) during this time. Cotton swabs were
extensively rolled and moved over either the left or right
hand (insides of both palms and fingers) of the volunteer.
After collection of the different body fluids and tissues, all
samples were immediately processed for RNA isolation.
Semen, menstrual blood and vaginal secretion samples
were collected and processed as described previously [10].
For sensitivity testing of the skin-targeted markers, left
and right thumbprints of five individuals were collected on
clean, sterilised glass slides. Samples were either immedi-
ately processed for RNA isolation or stored in dust-free,
non-humid conditions for 6.5 months. Thumbprints were
then collected either by wet–dry swabbing or the
Pinpoint™ Slide RNA Isolation System II (Zymo Research,
California, USA). In brief, swabbing was performed by
rolling with simultaneous downward pressure a cotton or
flocked swab moistened with lysis buffer over the thumb-
print area, followed by collection of any excess moisture or
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from [20]). The Pinpoint™ Slide RNA Isolation System II
utilises a proprietary solution, which is painted over the
fingerprint, embedding the cellular material within the
solution as it dries. Approximately 150 μl of Pinpoint™
Solution was spread in a thin layer across the print using an
elongated 20 μl pipette tip. Slides were dried for 30 min at
room temperature, with the dried solution and embedded
print lifted and placed in a sterile micro centrifuge tube.
Ascertainment of candidate genes
The initial ascertainment of genes was performed using the
built-in function of GNF SymAtlas database (now the
BioGPS Gene Portal Hub) of gene expression in human
tissues [21]. All candidate genes with expression 10-fold
higher in skin than the median expression across all other
tissues in this database were ascertained. This online
database on gene function and structure based on human
microarray expression data from the Genomics Institute of
the Novartis Research Foundation. Users can view expres-
sion patterns across (currently) 84 tissues and can view
detailed annotation information on many of the transcripts
(http://www.biogps.gnf.org). In addition, KRT9 was ascer-
tained from the literature as being specifically expressed in
the palms and soles of the feet [22]. Commonly used
reference genes were selected from the literature for
examination of their amplification in skin and other
forensically relevant tissues [4, 5, 7, 8, 23–26].
RNA isolation and cDNA synthesis
Half a millilitre of liquid blood (obtained by venipuncture), or
one blood soaked cotton swab (obtained by finger prick), was
first extracted by acid phenol-chloroform to remove the haem
and greatly increase RNA yield. After centrifugation, total
RNA was isolated from the upper phase with the Qiagen
RNeasy Plus Mini kit (QIAGEN GmbH, Hilden, Germany)
according to the manufacturer’s instructions. The same kit
was used for the saliva samples with the exception that during
the lysis step with RLT buffer, the saliva soaked cotton swabs
were incubated for 30 min at 56°C before RNA extraction.
Total RNA was isolated from skin swabs using the Qiagen
RNeasy Fibrous Tissue Mini kit (Qiagen) according to the
manufacturer’s instructions with minor adjustments; cotton
swabs were incubated for 30 min at 56°C in RLT buffer,
proteinaseKandwater,beforethecompletemixtureincluding
the swab was passed over a QiaShredder column (Qiagen),
after which the flow-through was incubated for another
10 min at 56°C. RNA extractions and subsequent DNase I
digestion from semen, menstrual blood and vaginal secretion
samples was performed as described previously [10]. The
quantity of total RNA was determined by a NanoDrop
ND-1000 spectrophotometer (Thermo Scientific, Wilming-
ton, DE, USA).
Total RNA from fingerprints was isolated using the
Pinpoint™ Slide RNA Isolation System II (Zymo Research
Corporation) according to the manufacturer’s instructions
with minor adjustments; following print collection with
Pinpoint™ solution as described above, the material was
incubated with 60 μl RNA digestion buffer and 15 μl
proteinase K for 4 h at 55°C. The lysate was then applied to
a Zymo-Spin Column, with the manufacturer’s protocol in
subsequent steps. An additional on-column DNase I
treatment performed between the two wash steps with an
incubation mixture of 10 μl DNase I and 70 μl RDD buffer
(Qiagen), for 15 min at room temperature.
The reverse-transcriptase (RT) reaction was performed
using RevertAid™ H Minus First StrandcDNASynthesis Kit
(Fermentas GmbH, St. Leon-Rot, Germany) according to the
manufacturer’s instructions for random hexamers protocol, in
a total volume of 20 μl. Each reaction contained 5–11 μlo f
total RNA. “No-RT controls” (i.e. controls without reverse
transcriptase) were performed to detect for genomic DNA
contamination.
Quantitative PCR
PCR primers for the initial screening of target genes
(CALML5, CDSN, DCD, DSC1, FLG, KRT1, KRT2A,
KRT9, KRT10, LOR and SCGB2A2) and five commonly
used reference genes (ACTB, B2M, GAPDH, PPIB and
UBC) were designed using Primer3 software so that the
forward and reverse primers were complementary to
different exons of the respective genes and most closely
located to the 3′ end of the corresponding RefSeq
complementary DNA (cDNA) (Supplementary Table S1).
Following marker selection, PCR primers and hydrolysis
probes (TaqMan gene expression assays) for CDSN, KRT9,
LOR and ACTB were commercially obtained (Applied
Biosystems, The Netherlands). Probes were labelled with
FAM (target genes) or VIC (reference gene) reporter dyes at
the 5′ end and a non-fluorescent quencher at the 3′ end of
the oligo in combination with MGB (Table 1). To ensure
that only mRNA, and not genomic DNA, was detected by
the tissue-specific PCR assays, PCR primers which spanned
exon junctions were used, resulting in small amplicons for
mRNA and very large or no product for genomic DNA.
The only exception for this was the primer set used for
LOR, as one of the two exons of this gene is too small for
priming; thus, one single exon was targeted. Therefore, all
samples and PCR conditions were also controlled so that
genomic DNA could not be amplified. During the course of
testing, the primer set for the reference gene ACTB had to
be changed to ensure amplification of small amounts of low
quality material. Initially, the amplicon size was 171 bp
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this appeared too long for efficient amplification and thus
was changed to a custom-designed primer/probe set
ACTB-74, with a 74-bp amplicon. As both primer sets
t a r g e tt h es a m et r a n s c r i p t ,r e f e r e n c eg e n eq u a n t i t a t i o nw a s
not affected.
Quantitative real-time PCR reactions (qPCR) for the
examination of candidate genes were performed with
custom-designed primers on an ABI 7300 PCR machine
(Applied Biosystems, The Netherlands) with the Maxima™
SYBR Green/ROX qPCR Master Mix (2X) (Fermentas
GmbH) using the following parameters: initial denatur-
ation at 94°C for 10 min, followed by 45 cycles of 94°C
for 15 s and 60°C for 30 s. In each PCR reaction, 2 μlo f
5-fold diluted cDNA was used as input. Specificity of the
primers and the absence of genomic DNA contamination
were checked with melting profiling and agarose gel
electrophoresis.
TaqMan gene expression assays were performed for
CDSN, KRT9, LOR and ACTB to test marker specificity
across different tissues and body fluids. qPCR reactions
were performed on a LightCycler® 480 Real-time PCR
System (Roche Diagnostics Nederland B.V.) with the
Maxima™ Probe/ROX qPCR Master Mix (Fermentas
GmbH) using the following parameters: initial denaturation
at 95°C for 10 min, followed by 50 cycles of 95°C for 10 s,
60°C for 30 s and 72°C for 1 s and a final cooling step to
40°C. qPCR amplifications were performed in a total
volume of 20 μl, with the reaction mix containing 10 μl
of PCR master mix, 1× primer/probe mix, 1.5 μlo f
undiluted cDNA and 7.5 μl of double-distilled water
(ddH2O). PCR reactions were performed in Lightcycler
480 Multiwell PCR plates (Roche). LightCycler 480
System Software v1.5 (Roche) was used to analyse the
qPCR data. Threshold cycle (Ct) measurements were
automatically determined by the software. The reference
gene ACTB was used to normalise the amplification signal
between the samples of different cellular origin, individuals
and amount of input cDNA. Comparative analyses between
skin, saliva, blood, semen, menstrual blood and vaginal
secretions were done with the delta Ct (ΔCt) method,
where ΔCt=Ct(target gene)−Ct(reference gene). Low ΔCt values
indicate high expression of a gene, whereas higher ΔCt
values indicate very low expression of a target gene in
relation to the expression of ACTB. If no signal was
detected from either the reference gene or target gene, the
sample was removed from analysis, although the number of
failures was noted.
Sensitivity and stability testing was performed with
commercial TaqMan primers and probes, with the excep-
tion of ACTB-74. As the amplicon given by the commercial
primers was too large to be suitable, custom primers were
designed as described above, and listed in Table 1. ACTB-
74 was duplexed with CDSN in the qPCR reactions. qPCR
reactions were performed on a LightCycler® 480 Realtime
PCR System (Roche) with the Maxima™ Probe/ROX
qPCR Master Mix (Fermentas GmbH). Amplifications
were performed in a total volume of 20 μl, with each
PCR reaction containing 5 μl of undiluted cDNA as input.
For the singleplex LOR and KRT9 amplifications, and
CDSN within the duplex, 1× primer/probe mix was used.
For ACTB-74 within the duplex, 1 μM forward and reverse
primers and 0.25 μM probe were used. Cycling parameters
were as listed above for the specificity testing. ΔCt values
for the target genes were calculated as listed above. If no
signal was detected from either the reference or target gene,
the sample was removed from analysis, although the
number of failures was noted.
All qPCR assays, including the commercially obtained
Taqman assays, for which the manufacturer states 100%
efficiency, as well as the endogenous controls ACTB-171
and ACTB- 7 4 ,w e r et e s t e da n dv e r i f i e dt op e r f o r mn e a r
100% PCR efficiency by performing standard curve
analysis (LightCycler 480 System Software v1.5) of
cDNA dilutions using skin biopsy samples (data not
shown).
Table 1 Three suitable skin-targeted mRNA markers and one reference mRNA marker, their Genbank accession number, PCR primer and probe
sequences and assay IDs (Applied Biosystems) with the reporter dye and the sizes of the qPCR amplified products
Gene Genbank accession
number
Primer/Probe sequence (5′→3′) Assay ID/reference Reporter dye Amplicon size (bp)
CDSN NM_001264.3 –
a Hs 00169911 m1 FAM 79
LOR NM_000427.2 –
a Hs 0189462. s1 FAM 105
KRT9 NM_000226.3 –
a Hs 00413861. m1 FAM 94
ACTB(171) NM_001101.2 –
a 4326315E (part number) VIC 171
ACTB(74) NM_001101.3 Forward: tgacccagatcatgtttgag Primer3 software HEX 74
Reverse: cgtacagggatagcacag
Probe: HEX-caccccagccatgtacg -TAMRA
aPrimer/Probe sequences of the commercially available Taqman assays are undisclosed by the manufacturer
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All statistical analyses were performed in SPSS v15.0
(SPSS Inc.)
Results
Testing of candidate genes
Ten skin candidate genes CALML5, CDSN, DCD, DSC1,
FLG, KRT1, KRT2A, KRT10, LOR and SCGB2A2 were
identified from the GNF SymAtlas database [21] as having
expression levels in skin 10-fold higher than the median
expression across all other tissues in this database. In
addition, KRT9 was chosen from the literature for being
specifically and solely expressed in the terminally differen-
tiated epidermis of palms and soles of hand and feet [22].
All candidate genes were experimentally examined via
qPCR in skin samples as well as in a variety of forensically
relevant body fluids, such as blood, menstrual blood,
semen, saliva and vaginal secretions for detectable levels
of expression. Five of the ascertained candidate genes
showed non-specific amplification (CALML5, DSC1, FLG,
KRT1 and KRT2A) among the samples tested, while three
(DCD, KRT10 and SCGB2A2) revealed expression signals
in skin samples expected to be too low for practical forensic
applications (data not shown). This initial screening
resulted in a panel of three mRNA markers that showed
considerably high expression in skin samples together with
over-expression in skin samples relative to all other
forensically relevant cell types tested (in the following
called “skin-targeted mRNA markers”), which we used in
further investigations: corneodesmosin (CDSN), loricrin
(LOR) and keratin 9 (KRT9).
In addition, five commonly used reference genes (ACTB,
B2M, GAPDH, PPIB and UBC)[ 4, 5, 7, 8, 23–26] were
tested in skin samples. Of those, the expression of ACTB
appeared to be most abundant in skin material (data not
shown). When further tested in the various forensically
relevant body fluids, ACTB showed similarly high levels of
expression in all cell types including skin (Fig. 1) and was
therefore chosen as reference mRNA marker in all further
qPCR testings.
Using ACTB as reference gene, we analysed the three
skin-targeted mRNA markers in palmar skin samples
serving as an appropriate skin sample type for the
envisioned future forensic application in the “touched
object” scenario. We observed high levels of expression
for all three mRNA markers in most individual samples
tested. Because the reference gene ACTB (i.e. its 171-bp
amplicon) was not detected in five of the 30 palmar
samples, we excluded these five samples from further
analyses. Using ACTB as the reference gene, we obtained
average ΔCt values of −4.46 for CDSN, −3.62 for LOR and
−0.67 for KRT9. No significant differences in ΔCt values
were observed between samples from left and right palms
within the same individual (Kolmogorov–Smirnov
Z=0.685,p=0.736); however, there was substantial variation
in ΔCt values between individuals (Kruskal–Wallis
χ
2=39.38, p<0.0001). As the Ct values of the reference
gene ACTB showed significant variation between but not
within individuals (i.e. between technical replicates), the
observed variation in ΔCt is most likely due to variation in
the amount of material deposited. CDSN and LOR were
detected in all samples, whereas KRT9 was not detected in
three of the 30 samples tested. However, given the high Ct
values observed in these three samples for the other two
skin-targeted mRNA markers, it appears that very little
material was collected initially with these samples, and thus,
KRT9 fell below the level of detection.
Specificity of skin-targeted mRNA markers
To further establish the specificity of the three skin-targeted
mRNA markers CDSN, LOR, and KRT9, we tested their
expression levels in non-skin samples, namely, blood
(venous and menstrual), saliva, vaginal secretions and
semen, as well as in palmar skin samples, using an enlarged
sample set (Fig. 2). Raw Ct values were normalised relative
to the expression of the identified reference gene ACTB
with primer set ACTB-171 for skin, saliva, finger prick and
venous blood, and primer set ACTB-74 for vaginal
secretions, menstrual blood and semen samples (see
methods for different ACTB assays). All three skin-
targeted mRNA markers showed significantly lower ΔCt
values in palmar skin samples, as compared to the non-skin
samples (ANOVA, F=442.27, p<0.0001). Only LOR was
detected in all tissues, but was at much higher levels in skin
than in non-skin samples, and these differences were
statistically significant (ANOVA, F=298.1, p<0.0001).
CDSN was below the detection threshold in semen, while
KRT9 was below the detection threshold in venous and
menstrual blood, as well as in semen. All other post hoc,
Bonferroni-adjusted comparisons between skin and non-skin
tissues were found to be highly significant, with p values
ranging from 1.27×10
−5 (LOR;s k i nv ss e m e n )t o2 . 4 4 ×
10
−48 (CDSN; skin vs fingerprick blood).
As both saliva and vaginal secretions contain epithe-
lial cells, it was unsurprising to find slightly higher levels
of expression of the mRNA markers within these
samples, compared to the expression of the mRNA
markers in other non-epithelial samples. However, skin
vs vaginal secretions and skin vs saliva expression levels
were significantly different for all skin-targeted mRNA
markers (all p<0.00001). In addition, higher expression
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KRT9 and LOR in various skin samples and across forensically
relevant body fluids: Palmar skin (L), n=15; Palmar skin (R), n=15;
Blood (fingerprick), n=15; blood (menstrual), n=3; blood (venous),
n=12; saliva, n=15; semen, n=2; vaginal, n=7. The box for each gene
represents the interquartile range (25–75th percentile), and the line
within this box is the median value. Bottom and top bars indicate the
minimum and maximum value of all the data, respectively, or 1.5
times the interquartile range of the data, whichever is smaller. Outlier
values are indicated by closed circles. Note the significantly lower
ΔCt values observed in skin compared to non-skin samples. An
asterisk indicates that the target gene was not detected in that tissue
Fig. 1 Ct values of the
reference gene ACTB from
biopsied skin samples and those
from forensically relevant body
fluids. Equal amounts of total
RNA (100 ng) were used for
cDNA synthesis in each sample.
Error bars represent the maxi-
mum and minimum observed
Ct values from two to four
individuals for each sample type
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collected via fingerpricks, compared with venous blood.
This is presumably due to low-level mixing of skin cells
with the blood in the fingerprick samples. However,
despite this, a clear distinction could be made between
ΔCt values of skin samples and non-skin samples for all
three skin-targeted mRNA markers. There are only two
exceptions: KRT9,w h e r eas i n g l er i g h tp a l m a rs a m p l e
displayed a ΔCt more characteristic of non-skin samples,
and LOR, where two samples have ΔCt values consider-
ably lower than the other vaginal secretion samples.
Excluding this one skin sample from the analysis allows
a ΔCt threshold value of 2.7 to be set for differentiating
skin from non-skin samples with our approach; any
sample below this value was attributed as being from
skin, while any sample with a ΔCt>2.7 was correctly
called as non-skin.
Sensitivity of skin-targeted mRNA markers
The sensitivity of the qPCR assays in detecting the three
skin-targeted mRNA markers, respectively, in low amounts
of skin material was tested using thumbprints of several
individuals that were set on glass slides. However, an
efficient method of recovering the cellular material and
mRNA had to be investigated first, to ensure that total
mRNA could be retrieved in sufficient quantity from
fingerprints left on the glass slides. Therefore, three
collection methods—wet/dry cotton swabbing [20], wet/
dry swabbing with flocked swabs and the Pinpoint™ Slide
RNA isolation System II kit (Zymo Research)—were
tested, and the results were compared. To ensure consis-
tency between samples, three donors (good, medium and
poor shedders, as determined by the overall success rate of
amplification of the target and reference genes, data not
shown) provided 5–10 thumbprints each and for each of the
sample collection/RNA isolation protocol. Overall, the
Pinpoint™ method proved to be the only one that allowed
reproducible detection of skin-targeted mRNA markers (data
not shown). With the other two methods, only the reference
gene ACTB amplified occasionally and only from samples
obtained from the good shedder, whereas the skin-targeted
mRNA markers could not be amplified successfully, most
likely due to insufficient yield from the thumbprint (data not
shown). Therefore, the Pinpoint™ method was used for skin
cell collection in all further experiments, particularly during
the sensitivity testing due to the low amount of material
expected.
All three skin-targeted mRNA markers proved to be
exceptionally sensitive for the detection of skin cells given
the assays applied (Fig. 3). From full thumbprints, all three
mRNA markers in all samples except one were detected
with a Ct value below 40, with average Ct values of 34.72
for CDSN, 36.38 for LOR, and 36.45 for KRT9 while the
average Ct for the reference gene ACTB was 35.8 (primer
set ACTB-74). Dropout of KRT9 was observed in one full
print, and the donor of this particular print appeared to be a
poor shedder based on the expression levels detected in
other genes and thumbprints examined. The ΔCt values
were generally below the 2.7 threshold as determined in the
previously described analysis, with the exception of the
LOR ΔCt (3.1) obtained from the poor shedder and the
KRT9 ΔCt at 2.8 of one other full thumbprint.
Furthermore, when half and quarter thumbprints were
analysed, it was noted that the Cts increased more than may
have been predicted based on sample size where an increase
in Ct of 1 would be expected for full-half print differences
and two for full-quarter prints. This may reflect differences
in the amount of mRNA deposited between prints tested, or
alternatively that the stochastic limit of qPCR detection was
reached, resulting in excessive variation between samples.
The average Cts observed for half prints were all below 40
cycles, but dropout was observed in one fifth CDSN and
LOR and three fifths KRT9 amplifications. The generally
lower expression of KRT9 resulted in the average ΔCt ratio
being above the 2.7 threshold (3.2) from half prints,
although CDSN and LOR were still below this level. The
quarter print samples showed considerably more dropout
(20% for ACTB, 40% for CDSN and LOR and 70% for
KRT9), as may be expected from such low amounts of
material collected from quarter prints. However, all samples
showed positive amplification for CDSN and, therefore,
were able to be correctly assigned as skin based on this
marker (average ΔCt 0.32), as well as three of the LOR
amplifications. All remaining LOR and all KRT9 amplifi-
cations from quarter prints would not have been identified
correctly as skin samples on the basis of the 2.7 ΔCt
threshold. Thus, as could be expected, as the level of
material present drops, there is an increasing risk of
misclassification of the sample as originating from a non-
skin source. Stochastic effects may result in inconsistent
ratios of the three target genes to the reference ACTB gene.
To prevent incorrect sample assignment, the limit of
detection threshold for each of the three skin-targeted
mRNA markers may be set at 40 cycles, beyond which
the ΔCt value may be inaccurate. This is particularly the
case when the ACTB Ct is above 35, indicating only minute
traces of material are present. In the future, a larger dataset,
consisting of many more samples, should be used to
precisely define more specific limits.
Time wise stability of skin-targeted mRNA markers
To obtain an indication about the time-wise stability of the
expression signals of the three skin-targeted mRNA
markers, we analysed full thumbprints stored at room
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processed immediately after deposition, no significant
difference in expression signals were observed for any of
the three skin-targeted mRNA markers, with ΔCt values
remaining relatively stable (Fig. 4; ANOVA; CDSN,
F=0.002, p=0.965; KRT9, F=3.992, p=0.081; LOR,
F=0.911, p=0.357). Notably, the reference mRNA marker
ACTB also remained stable, with a non-significant increase
of 0.1 in Ct (F=0.021, p=0.886). Only KRT9 showed a
(albeit not statistically significant) trend towards decreasing
detection levels with increasing thumbprint storage time,
with average Ct values increasing by 1.8 cycles and ΔCt by
1.6. These results indicate that the KRT9 transcript may be
more susceptible to time-wise degradation than the two
other skin-targeted mRNA markers, as KRT9 was not
detected in 40% of samples stored for 6.5 months.
Discussion
Although touched objects and fingerprints have been used
in forensic biology to generate DNA profiles for over
10 years [27], there is not a definitive test for determining
the presence of skin epithelial cells in a biological trace.
The inability to prove that a suspect’s DNA originated
specifically from skin cells can lead to challenges against
DNA evidence in court. For instance, a suspect who has
been identified by DNA profiling may allege that his/her
DNA profile is present on an item found at a crime scene
due to speaking or sneezing over it, but that he/she did not
touch or use the item in question from which his/her DNA
profile was obtained. Alternatively, a person may claim
sexual assault with a specific object, while an alleged
Fig. 4 Time-wise stability of three skin-targeted mRNA markers
CDSN, KRT9 and LOR after 6.5 months of thumbprint storage. No
significant differences were observed between freshly analysed
samples (n=5) and thumbprints stored for 6.5 months at room
temperature (n=10) for all three mRNA markers
Fig. 3 Detection sensitivity
of qPCR assays for three
skin-targeted mRNA markers
CDSN, KRT9 and LOR, with
full (n=5), half (n=5) and
quarter (n=10) thumbprints.
All sample points below the line
would be correctly identified as
originating from skin, when
applying a threshold of 2.7
(see specificity results for
further details). An asterisk
indicates that dropout was
observed, with the number
specified for each marker
and fingerprint size
260 Int J Legal Med (2011) 125:253–263suspect whose DNA profile was collected from such object
may claim that he/she simply touched the object instead of
sexually assaulting the person. While histological staining
or alternative light source methods can be used, these do
not provide conclusive evidence for the presence of skin
cells, lack the required sensitivity or reduce the efficiency
of DNA profiling and, therefore, are not in common usage.
Instead, an mRNA assay targeting genes that are highly
over-expressed in skin relative to other cell types that can
be expected at a crime scene, such as forensically relevant
body fluids, would allow the conclusive determination of
the presence of epithelial cells in an extract and is
compatible with automation and parallel analysis with
conventional DNA markers, such as forensic STRs.
There are various mRNA transcripts with putative
over-expression in skin available in public databases and
in the literature that are usually derived from genome-
wide gene expression data. However, expression signals
obtained with microarray probes do not always agree
with those derived from specific qPCR experiments, and
some of the cell types highly relevant to forensic analysis
are usually not covered by expression databases. Fur-
thermore, sensitivity limits between array-based methods
and qPCR are different, which may lead to further
discrepancies. Hence, careful experimental validation of
candidate mRNA markers obtained from expression
databases is needed using a methodology suitable for
forensic applications (sucha sq P C R ) ,a sw e l la st e s t i n g
forensically relevant cell types.
P e r f o r m i n gs u c has t u d y ,w eh a v ei d e n t i f i e dt h r e e
mRNA markers, namely KRT9, CDSN and LOR, as being
suitable for skin identification in the forensic context. That
we found eight of the 11 candidate skin mRNA markers
ascertained from a large and widely used expression
database either not specific or not sensitive may be
explained by the factors listed above. All three genes
identified here as representing suitable skin mRNA markers
are involved in the differentiation or maintenance of the
keratinisation and cornification of the skin. KRT9 belongs
to the superfamily of intermediate filament proteins
expressed in all different epithelial cell types. There are
20 human epithelial keratins, all functioning as important
building blocks composing the cytoskeleton of epithelial
cells, and they all also have their own specific function or
timing in the cellular dynamics. They are expressed, mostly
in pairs or subsets, during terminal skin cell differentiation,
in the different stages of development and in different
epithelia [22]. KRT9, a type I keratin, is expressed only in
the suprabasal cells of the epidermis and has previously
been found to be specifically expressed in palmar and
plantar skin [22]. CDSN, a 52- to 56-kDa basic glycopro-
tein, is specific to the cornified epithelia and the inner root
sheath of hair follicles [29]. LOR is initially expressed in
the granular layer of the epidermis during cornification and
comprises of about 80% of the total protein mass of the
cornified envelope [29, 30]. Both CDSN and LOR are
involved in the assembly of the epidermal cornified cell
envelope, with CDSN mainly detected in uppermost
spinous and granular layers [29, 32, 33, 34].
Recently, Schulz et al. [28], in a study focussing on
antibodies against various cytokeratins, found KRT10 to be
specifically expressed in human skin samples. While we
were able to confirm its specificity to skin, we found the
expression level within palmar and fingerprint skin samples
too low to be practically useful for trace samples in forensic
applications (data not shown).
We have observed high over-expression of the mRNA
markers KRT9, CDSN and LOR in skin, compared to blood,
saliva, menstrual blood, semen and vaginal secretions
(Fig. 2). Although low levels of expression were observed
for all three genes in some non-skin samples, skin samples
showed considerably higher levels of expression of the
three skin-targeted mRNA markers. This observed strong
difference in expression intensity between skin and non-
skin samples allows the three mRNA markers to differen-
tiate skin from non-skin samples based on the ΔCt
measure. In particular, the clear distinction in ΔCt values
between skin samples on one side and vaginal and saliva
samples on the other indicates that the three mRNA
markers are expressed predominately in cornified, kerati-
nised epithelium. Oral and vaginal epithelium and skin
epidermis are very similar, but differ in the proportion of
cornified epithelial cells, which could be an explanation for
the slightly higher level of expression of the target genes
we detected in vaginal secretion and saliva compared to the
other non-skin tissues. The results from fingerprick blood
samples also indicates that low-level skin cell contamina-
tion of a body tissue or fluid, such as in blood obtained
using fingerpricks, will not cause the test to falsely indicate
skin as the major component. However, the lower ΔCt
observed, compared to a non-mixed blood sample such as
venous blood, may indicate that skin cells are present in the
minority in the fingerprick blood samples we used. For
completely reliable mixture determination, we advise the
incorporation of the skin-targeted mRNA markers intro-
duced here into multiplex assays additionally including
mRNA markers targeting all alternative forensically rele-
vant cell types.
The reference gene ACTB (β-actin), used here for
normalising expression signals of skin-targeted mRNA
markers, was chosen from five commonly used genes
(ACTB, B2M, GAPDH, PPIB and UBC,[ 4, 5, 7, 8, 23–26]),
which were all tested for ubiquitous expression across
forensically relevant samples including skin. Of all refer-
ence candidate genes tested, ACTB was the most abundant-
ly expressed in skin cells, with the least variation across all
Int J Legal Med (2011) 125:253–263 261cell types in this study. Actins are highly conserved proteins
that are involved in cell motility, structure and integrity.
ACTB is a major constituent of the contractile apparatus and
one of the two non-muscle cytoskeletal actins. Although
18S rRNA is often used in forensic gene expression studies
and in many other gene expression studies [4, 7, 24, 26],
caution should be taken when using rRNA as reference for
mRNA targets, due to observed imbalances between
mRNA and rRNA fractions [26]. Furthermore, rRNA
molecules are not present in purified mRNA samples, and
the high abundance of 18S rRNA compared to target
mRNA markers can create difficulties in the normalisation
procedure [26]. Ideally, more than one reference gene
would be applied, and additional candidate genes may be
screened in future studies for suitability in trace samples.
However, it should be kept in mind that the low amount of
material present with touched objects and thus available for
skin cell determination significantly limits the number of tests
thatcanbeperformedonasample,alsolimitingthenumberof
reference genes that can be analysed from such sources
(unless multiplexing can be employed successfully).
To ensure that the protocols would be suitable for
practical forensic applications, such as to analyse samples
taken from touched objects, primer sets were chosen to
produce small amplicons ranging from 79 to 105 bp for the
three skin-targeted mRNA markers. Initially, a commercial-
ly available assay for the reference gene ACTB was used,
with an amplicon size of 171 bp. However, it was found out
that this commercial assay was unable to amplify samples
of low quantity/quality (such as fingerprints), and therefore,
we developed and applied to such samples a new ACTB
assay with a reduced amplicon size of only 74 bp.
Sensitivity testing of CDSN, LOR, KRT9 and reference
gene ACTB-74 revealed that all four mRNA markers were
stably detected from full thumbprints (Fig. 3). The
sensitivity decreased with the size of the fingerprint sample
decreasing, resulting in seven of 15 amplification/threshold
failures for half thumbprints and 21 of 30 for quarter
thumbprints. However, given the similar specificity of all
three skin-targeted mRNA markers used, a single marker is
expected to be sufficient for skin identification. Conse-
quently, using a single marker returning a ΔCt below the
2.7 threshold, 80% of half thumbprints could be correctly
classified, as well as 70% of the quarter prints. The
observed high level of sensitivity of the assays employed for
the suitable three skin-targeted as well as the ACTB-74
referencemarkersensuresthatskindepositscanbedetectedin
samples,whichmaycontainonlytraceamountsandforwhich
currently forensic scientists cannot postulate an origin for. As
a further prerequisite for future applications to forensic case
work, the three skin-targeted mRNA markers (as well as the
ACTB reference mRNA) were shown to be remarkably
stable over sample storage time, with no significant signal
loss observed over 6.5 months of fingerprint sample storage
(although longer time intervals should be investigated in
future studies). Despite a slight decrease in KRT9 expression
after 6.5 months, half of the prints still displayed positive
amplification with ΔCt below the 2.7 threshold.
Finally, we would like to note that co-extraction of both
DNA and RNA from the same sample followed by parallel
STR and mRNA amplification is possible, and a suitable
method has been demonstrated recently [35]. Thus, applying
o u ra p p r o a c hf o rt h ei d e n t i f i c a t i o no fs k i nt oc o - e x t r a c t e dc a s e
work material would allow the conclusive linking within the
same sample of the cellular origin of the STR profile obtained
while limiting reagent cost and sample consumption.
Conclusion
From our results, it can be concluded that three mRNA
markers CDSN, LOR and KRT9, in combination with the
ACTB reference mRNA marker, a n da n a l y s e dv i at h e
described qPCR assays, are highly suitable for identifying
skin cells, including small traces of skin material. These
mRNA markers fill a gap in the current portfolio of mRNA
markers for cellular origin identification in forensic appli-
cations, allowing the rapid and accurate identification of
minute quantities of skin materials. Although the approach
for skin identification introduced here can be informative
when applied on its own, we recommend the inclusion of
(one or more of) the skin-targeted mRNA markers
presented here in multiplex systems, which additionally
include mRNA markers targeting other forensically relevant
cell types (as well as more than one reference gene). In
general, we recommend, as emphasised before [8], that in
forensic applications, a cell type/tissue should be identified
by the presence of (e.g. mRNA) markers specific for the
relevant cell type/tissue together with the absence of
markers specific for alternative cell types/tissues, which is
most efficiently achieved by combining all relevant markers
in a sensitive and reliable multiplex assay. Therefore, our
study not only provides suitable mRNA markers for
identifying skin cells, including minute amounts of skin
material but also contributes to the future completion of
suitable multiplex mRNA systems for the reliable determi-
nation of all cellular types usually expected in forensic
samples including skin.
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